Criam is a medtech company based in Portugal that focuses on fast and affordable blood analysis for disease detection. The company, whose name stands for Chemical Reaction and Image Analysis for Mobility, has been operating since 2016. Criam's core mission is to provide quick, cost-effective, and on-the-spot blood analysis, offering individuals immediate insights into their health and wellness status.
The firm operates in a variety of industries, including Big Data, Biotechnology, Enterprise Software, Hardware, Health, Health Care, Information Technology, Medical Devices, and Pharmaceutical. Despite its innovative approach and potential, there is no publicly available information regarding the company's recent investment and the involved investors.